These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21193308)

  • 1. Exploration of SAR regarding glucose moiety in novel C-aryl glucoside inhibitors of SGLT2.
    Park EJ; Kong Y; Lee JS; Lee SH; Lee J
    Bioorg Med Chem Lett; 2011 Jan; 21(2):742-6. PubMed ID: 21193308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrimidinylmethylphenyl glucoside as novel C-aryl glucoside SGLT2 inhibitors.
    Lee J; Kim JY; Choi J; Lee SH; Kim J; Lee J
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7046-9. PubMed ID: 20952196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Aryl glycoside inhibitors of SGLT2: Exploration of sugar modifications including C-5 spirocyclization.
    Robinson RP; Mascitti V; Boustany-Kari CM; Carr CL; Foley PM; Kimoto E; Leininger MT; Lowe A; Klenotic MK; Macdonald JI; Maguire RJ; Masterson VM; Maurer TS; Miao Z; Patel JD; Préville C; Reese MR; She L; Steppan CM; Thuma BA; Zhu T
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1569-72. PubMed ID: 20149653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel macrocyclic C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents.
    Kim MJ; Lee SH; Park SO; Kang H; Lee JS; Lee KN; Jung ME; Kim J; Lee J
    Bioorg Med Chem; 2011 Sep; 19(18):5468-79. PubMed ID: 21868239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolylmethyl ortho-substituted phenyl glucoside library as novel C-aryl glucoside SGLT2 inhibitors.
    Lee SH; Kim MJ; Lee SH; Kim J; Park HJ; Lee J
    Eur J Med Chem; 2011 Jul; 46(7):2662-75. PubMed ID: 21514014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.
    Xu B; Feng Y; Lv B; Xu G; Zhang L; Du J; Peng K; Xu M; Dong J; Zhang W; Zhang T; Zhu L; Ding H; Sheng Z; Welihinda A; Seed B; Chen Y
    Bioorg Med Chem; 2010 Jun; 18(12):4422-32. PubMed ID: 20576578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of pyridazine and thiazole analogs as SGLT2 inhibitors.
    Kang SY; Song KS; Lee J; Lee SH; Lee J
    Bioorg Med Chem; 2010 Aug; 18(16):6069-79. PubMed ID: 20637636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
    Xu B; Feng Y; Cheng H; Song Y; Lv B; Wu Y; Wang C; Li S; Xu M; Du J; Peng K; Dong J; Zhang W; Zhang T; Zhu L; Ding H; Sheng Z; Welihinda A; Roberge JY; Seed B; Chen Y
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4465-70. PubMed ID: 21737266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors.
    Yao CH; Song JS; Chen CT; Yeh TK; Hsieh TC; Wu SH; Huang CY; Huang YL; Wang MH; Liu YW; Tsai CH; Kumar CR; Lee JC
    Eur J Med Chem; 2012 Sep; 55():32-8. PubMed ID: 22818040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents: 1,3,4-Thiadiazolylmethylphenyl glucoside congeners.
    Lee J; Lee SH; Seo HJ; Son EJ; Lee SH; Jung ME; Lee M; Han HK; Kim J; Kang J; Lee J
    Bioorg Med Chem; 2010 Mar; 18(6):2178-2194. PubMed ID: 20181486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Aryl glucoside SGLT2 inhibitors containing a biphenyl motif as potential anti-diabetic agents.
    Ding Y; Mao L; Xu D; Xie H; Yang L; Xu H; Geng W; Gao Y; Xia C; Zhang X; Meng Q; Wu D; Zhao J; Hu W
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2744-8. PubMed ID: 26026363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally constrained spiro C-arylglucosides as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.
    Lv B; Feng Y; Dong J; Xu M; Xu B; Zhang W; Sheng Z; Welihinda A; Seed B; Chen Y
    ChemMedChem; 2010 Jun; 5(6):827-31. PubMed ID: 20414917
    [No Abstract]   [Full Text] [Related]  

  • 13. O-Spiro C-aryl glucosides as novel sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.
    Xu B; Lv B; Feng Y; Xu G; Du J; Welihinda A; Sheng Z; Seed B; Chen Y
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5632-5. PubMed ID: 19700318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Indolylglycosides bearing modifications at the glucose C6-position as sodium-dependent glucose co-transporter 2 inhibitors.
    Chu KF; Yao CH; Song JS; Chen CT; Yeh TK; Hsieh TC; Huang CY; Wang MH; Wu SH; Chang WE; Chao YS; Lee JC
    Bioorg Med Chem; 2016 May; 24(10):2242-50. PubMed ID: 27075813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of sodium glucose co-transporter 2 inhibitors as anti-diabetic agents.
    Washburn WN
    Expert Opin Ther Pat; 2009 Nov; 19(11):1485-99. PubMed ID: 19852718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design and synthesis of novel SGLT2 inhibitors: C-glycosides with benzyltriazolopyridinone and phenylhydantoin as the aglycone moieties.
    Guo C; Hu M; DeOrazio RJ; Usyatinsky A; Fitzpatrick K; Zhang Z; Maeng JH; Kitchen DB; Tom S; Luche M; Khmelnitsky Y; Mhyre AJ; Guzzo PR; Liu S
    Bioorg Med Chem; 2014 Jul; 22(13):3414-22. PubMed ID: 24842618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium glucose co-transporter 2 (SGLT2) inhibitors: novel antidiabetic agents.
    Washburn WN
    Expert Opin Ther Pat; 2012 May; 22(5):483-94. PubMed ID: 22583331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus.
    Imamura M; Nakanishi K; Suzuki T; Ikegai K; Shiraki R; Ogiyama T; Murakami T; Kurosaki E; Noda A; Kobayashi Y; Yokota M; Koide T; Kosakai K; Ohkura Y; Takeuchi M; Tomiyama H; Ohta M
    Bioorg Med Chem; 2012 May; 20(10):3263-79. PubMed ID: 22507206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel thiophenyl C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents.
    Lee SH; Song KS; Kim JY; Kang M; Lee JS; Cho SH; Park HJ; Kim J; Lee J
    Bioorg Med Chem; 2011 Oct; 19(19):5813-32. PubMed ID: 21906953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
    Ohtake Y; Sato T; Matsuoka H; Kobayashi T; Nishimoto M; Taka N; Takano K; Yamamoto K; Ohmori M; Higuchi T; Murakata M; Morikawa K; Shimma N; Suzuki M; Hagita H; Ozawa K; Yamaguchi K; Kato M; Ikeda S
    Bioorg Med Chem; 2012 Jul; 20(13):4117-27. PubMed ID: 22652255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.